Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xianlu Gao
Observed name:
Xian‐lu Gao
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
South China Normal University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0001-9940-6240
Observed ORCID:
0009-0001-9940-6240
OpenAlex ID:
A5101048315
ZIF-67 with Argon annealing treatment for visible light responsive degradation of organic dyes in a wide pH range
2019
·
Chen Yuan
, Pengfei Cheng
, et al.
·
Microporous and Mesoporous Materials
·
59
Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinoma
2023
·
Shida Yan
, Lili Liu
, et al.
·
Clinical & Translational Oncology
·
16
Clinicopathologic characteristics of HPV-associated head and neck squamous cell carcinoma in Southern China: long-term retrospective study of 400 cases
2024
·
Mingyuan Du
, Qiaohong Lin
, et al.
·
Therapeutic Advances in Medical Oncology
·
8
Prognostic factors of oropharyngeal minor salivary gland carcinoma in Southern China: a long-term follow-up observational study
2026
·
Wenmei Jiang
, Liyan Li
, et al.
·
Journal of Cranio-Maxillofacial Surgery
·
1
Adjuvant radiotherapy for patients with clinical T3–4 oral and oropharyngeal cancer who achieved major pathologic response after neoadjuvant immunochemotherapy and surgery: a propensity score-matched retrospective study
2026
·
Menghua Li
, Shiyan Yang
, et al.
·
Frontiers in Immunology
·
1
PDF
Mismatch repair protein imbalance in head and neck squamous cell carcinoma: associations with clinical features and survival
2026
·
Chulin Yang
, Mingyuan Du
, et al.
·
Therapeutic Advances in Medical Oncology
·
1
Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic Squamous Cell Carcinoma of Unknown Primary
2025
·
Xianlu Gao
, Shuwen Fu
, et al.
·
Cancer Medicine
·
1
PDF
Factors Associated with IgG/IgM Levels after SARS-CoV-2 Vaccination in Patients with Head and Neck Cancer
2024
·
Wei Liao
, Haoyu Liang
, et al.
·
Tropical Medicine and Infectious Disease
·
1
PDF
Clinicopathological features and prognosis of anaplastic and poorly differentiated thyroid carcinoma: Insights on treatment strategies from a 28-year real-world study spanning the immunotherapy era.
2026
·
Mingyuan Du
, Xianlu Gao
, et al.
·
Journal of Clinical Oncology
Omitting postoperative radiotherapy after pathologic complete response to neoadjuvant immunochemotherapy for patients with locally advanced head and neck squamous cell carcinoma: Survival and patient-reported outcomes.
2026
·
Shuwei Chen
, Shiyan Yang
, et al.
·
Journal of Clinical Oncology
Updated results of adjuvant toripalimab for locally advanced head and neck squamous cell carcinoma patients who achieved pathological complete response after neoadjuvant immunochemotherapy and surgery: A single-arm, phase II trial.
2025
·
Shuwei Chen
, Shida Yan
, et al.
·
Journal of Clinical Oncology
Treatment Outcomes of Squamous Cell Carcinoma of the Soft Palate and the Prognostic Significance of HPV /p16 Status
2025
·
Meng‐hua Li
, Xing Zhang
, et al.
·
Head & Neck
Show more works
View as search
Works count:
12
Citation count:
88
H-index:
3
I10-index:
2
Year
Topic
Type